STABLE ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID

The present invention relates to a stable oral formulation containing 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof as an API. Being characterized by the maintenance of stability even though containing no stabilizers as excipients, the sta...

Full description

Saved in:
Bibliographic Details
Main Authors YUN, Duck Il, LEE, Sun, PARK, Junghong, YOO, Seok Cheol, SUN, Hyun Ji
Format Patent
LanguageEnglish
Published 08.06.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a stable oral formulation containing 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof as an API. Being characterized by the maintenance of stability even though containing no stabilizers as excipients, the stable oral formulation according to the present invention contains an increased content of API in place of the inclusion of a stabilizer and as such, can be improved in terms of dose convenience.
Bibliography:Application Number: AU20210390901